1986
DOI: 10.1016/0165-0327(86)90025-x
|View full text |Cite
|
Sign up to set email alerts
|

Repeated dexamethasone suppression test in depressed patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
2
0

Year Published

1987
1987
2002
2002

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(3 citation statements)
references
References 27 publications
1
2
0
Order By: Relevance
“…We replicated the findings of Maes et al (26, 27) that the significant positive correlation between post‐DST maximum serum cortisol level and severity of depressive symptoms in the patient group was accounted for by women, but not men (29). This selective relationship for women was maintained following treatment with carbamazepine despite a threefold elevation in the mean maximum serum cortisol levels.…”
Section: Discussionsupporting
confidence: 89%
See 1 more Smart Citation
“…We replicated the findings of Maes et al (26, 27) that the significant positive correlation between post‐DST maximum serum cortisol level and severity of depressive symptoms in the patient group was accounted for by women, but not men (29). This selective relationship for women was maintained following treatment with carbamazepine despite a threefold elevation in the mean maximum serum cortisol levels.…”
Section: Discussionsupporting
confidence: 89%
“…Several studies have shown a correlation between post‐DST serum cortisol level and severity of depressive symptoms (26–28). Most such studies combine all subjects regardless of gender or age.…”
Section: Introductionmentioning
confidence: 99%
“…Finally, antidepressant drugs such as desipramine, imipramine and amytriptyline (23) are able to decrease HPA activity. The fact that patients who do not respond to antidepressant treatment continue to have HPA dysregulation (24) supports a causal relationship between normalization of stress hormone regulation and clinical recovery. Antidepressants may be able to down‐regulate HPA activity by decreasing CRH gene expression in the paraventricular nucleus of the hypothalamus (25) and by increasing corticosteroid receptor sites in brain regions known to mediate the inhibitory effects of glucocorticoids on subsequent HPA activity, thereby increasing the feedback inhibition over the HPA axis (26).…”
Section: Prevention Of Side‐effects With Antidepressantsmentioning
confidence: 99%